Information Provided By:
Fly News Breaks for November 28, 2016
CVE
Nov 28, 2016 | 07:51 EDT
Goldman removed Cenovus from the Conviction Buy List citing recent outperformance and fewer catalysts in 1H 2017 and maintained its $18 price target on shares.